Buccisano, F., Palmieri, R., Piciocchi, A., Arena, V., Maurillo, L., Del Principe, M.-I., Paterno, G., Irno-Consalvo, M.-A., Ottone, T., Divona, M., Conti, C., Fraboni, D., Lavorgna, S., Arcese, W., Voso, M. T. and Venditti, A. (2022) “Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial”, Haematologica. Pavia, Italy, 107(12), pp. 2823-2833. doi: 10.3324/haematol.2021.279777.